As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers ...

NASH drug Rezdiffra exceeded all expectations in the recent quarterly earnings release. The stock rose more than 50% in a few days – and the company now has a market cap of close to $8 billion.

Novo Nordisk has launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

Ozempic, Wegovy and Mounjaro are often the most popular weight loss drugs. While these medications help people lose weight, they have undesirable side effects. Now, scientists at the University of ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

The Ipsos survey of 1,078 adults found 24% of people would use weight-loss jabs if they were provided for free by the health ...

Despite semaglutide's quick rise in popularity ... Those with end-stage kidney disease undergoing dialysis or those with a ...

“But the widespread use for weight-loss drugs mimicking the FDA-approved versions has ... mpox in a traveler You will likely ...

Drug manufacturers have increased their production, and some such as Novo Nordisk have asked the FDA to ban further production of compounded versions of their drugs. If that happens, Lavin says many ...

Novo Nordisk launches its weight-loss drug Wegovy in China after approval by local health authorities in June.